Fluidigm Shares Volatile; Citron Research Tweets '$FLDM to $35 and higher. FDA Emergency Use Authorization first step. Company will change COVID-19 testing forever as their saliva-based test Demonstrated 100 Percent Agreement with Nasopharyngeal Assays'